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Abstract
Background Pilonidal disease is a troublesome acquired condition for whom various surgical treatments have been proposed 
with relatively high recurrence and complication rates. Since EPSiT technique has been described in 2013, it became an 
alternative treatment in adult practice. Our study reports the results of a multicentre series of pediatric patients who under-
went EPSiT procedure over a 21-month period.
Methods Between July 2015 and March 2017, all consecutive patients undergoing EPSiT in four different pediatric surgi-
cal units have been enrolled. Details regarding demographic data, detailed surgical procedure, outcome and complications 
have been recorded.
Results A total of 43 patients underwent EPSiT procedure. Mean age was 15 years. There was a slight female preponder-
ance. Mean weight and height at surgery were 67 kg and 168 cm, respectively. In 14% of cases a previous ineffective pro-
cedure was performed. Mean length of procedure was 34 min and median hospital stay was 24 h (12–72 h). Median length 
of follow-up was 4 months (range 3–18 months). Complications leading to reoperation were reported in 9% of cases with 
an overall resolution rate of 88%.
Discussion EPSiT proved to be feasible and safe even in the pediatric population. The effectiveness and safety of the proce-
dure suggest that this technique can represent a valid alternative for the treatment of pilonidal disease in children.
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Introduction
Pilonidal disease is an acquired condition characterized 
by the presence of median or paramedian openings at the 
intergluteal groove deriving from ingrowing of hair into the 
deep sacrococcygeal subcutaneous tissue [1]. Sondenaa et al. 
reported in 1995 the most salient clinical features of patients. 
The calculated incidence of the disease proved to be of 26 
into 100,000 with a strong male preponderance. Reported 
male-to-female ratio was 2.2:1 [2]. The onset in adoles-
cence seems to be due to the increased sebum and hirsutism 
compared to younger children [1]. The management of this 
annoying issue, which can have an onset up 2 years before 
medial referral, is debated and many different approaches 
have been proposed so far [1]. Some authors suggested to 
treat the disease by epilation only, others suggest to simply 
go for sinus incision and drainage, others suggest marsupial-
ization, radical excision with open wound or direct closures. 
Recently full-thickness flap closures have been suggested 
to improve results. Regardless of the adopted treatment, the 
recurrence rate of pilonidal disease proved to remain stable 
and ranges between 20 and 30% of cases [3–10]. Recently, 
Meinero et al. published a new minimally invasive technique 
for the treatment of pilonidal disease in adults [11]. The 
technique was named endoscopic pilonidal sinus treatment 
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(EPSiT) and was demonstrated to have a surprisingly low 
recurrence rate, lower than 10% [11, 12]. This multicentric 
study is aimed at reporting the results of EPSiT in patients 
younger than 18 years of age and at providing details regard-
ing this series of patients treated over a 21-month period.
Patients and methods
Study period was between 1st of July 2015 and 30th of 
March 2017 (21 month period).
All consecutive patients admitted during the study period 
for the treatment of pilonidal disease by the participat-
ing pediatric surgery units in Genoa, Alessandria, Naples 
and Legnano were enrolled. A specific informed consent, 
describing available alternatives, details of the technique and 
expected complications, was signed by the parents.
Inclusion criteria
1. Patients younger than 18  years of age (17  years, 
11 months, 30 days),
2. Pilonidal disease with chronic discharge, inflammation 
or abscess,
3. Surgeon trained in EPSiT technique.
Exclusion criteria
1. Patients older than 18 years of age,
2. Follow-up shorter than 3 months (based on the reported 
incidence of delayed healing occurring within the first 
2 months postoperatively [11], patients with a shorted 
follow-up were excluded to avoid miscategorising),
3. Immunocompromized patients with a high likelihood of 
persistence or recurrence,
4. Refusal of parents to sign informed consent.
All authors in the four participating units prospectively 
recorded demographic data, diagnostic details, presence 
of co-morbidities, preoperative imaging, previous surgical 
treatments, weight and height at surgery, detailed surgical 
information, duration of EPSiT procedure, type of anaes-
thesia, postoperative pain assessed 6  h postoperatively 
with visual numeric pain distress analogue scale (VAS), 
length of hospitalization, type and duration of antibiotic 
treatment, length of follow-up and complications observed 
in the medium to long term. Data were stored in a digital 
database according to Data Protection Act. Of note, most of 
the patients belonging to the series from Naples have been 
already published and described under the term PEPSiT pro-
cedure, which merely represents the pediatric application of 
the EPSiT technique [16].
Technique
All pediatric surgeons performing EPSiT (APP, CM, CE, 
and AD) had attended a coloproctology course to train on 
the technique and had been supervised by expert surgeons 
during their learning curve. In all centers EPSiT was per-
formed according to what reported by Meinero and co-
workers [11, 12]. The technique consists of:
1. Patients are prepped using either povidone solutions or 
chlorexidine.
2. A 2% solution of either saline or mannitol + glycine is 
used to perform fistuloscopy and to irrigate the pilonidal 
sinus.
3. Either a 3.3 mm standard co-axial pediatric Cystoscope 
or a 10 Ch Fistuloscope (Karl Stortz, 78532 Tuttlingen, 
Germany) are used to perform the procedure.
4. High-pressure irrigation of the fistula and/or of the pilo-
nidal cavity is performed to achieve enlargement of their 
internal lumen.
5. Fistuloscopy and direct visualization of the internal lin-
ing of the pilonidal cavity permit the identification of all 
side openings and tracts and the removal of all hair and 
follicles.
6. High power electrocoagulation with monopolar dia-
thermy under direct endoscopic view of the inner aspect 
of the fistula and of all cavitation and side tracts.
7. Removal of debris and of all residual hair and follicles 
under direct visualization.
8. Electrocoagulation of bleeding vessels and complete 
removal of the external opening of the fistula tracts.
Follow‑up and definitions
Patients were followed up on a regular basis in an out-
patient pediatric surgical setting to check for the correct 
dressing and wound irrigation, as previously reported 
by Meinero in his original description [11]. All patients 
underwent a single long-term clinical re-evaluation by a 
qualified pediatric surgeon that was undertaken after a 
median of 4 months (3–16 months) to collect results for 
this study. Outcome measures were recorded according to 
the following definitions:
• Recurrence was defined as “persistence of discharge 
after more than 3 months with either abscess formation, 
infection or local pain and discomfort”.
• Delayed healing was defined as “wound closure occur-
ring after more that 6 weeks postoperatively”: this issue 
was mostly due to granuloma formation requiring topic 
silver nitrate administration.
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• Infection was defined as “persistent smelly discharge with 
pain and redness possibly associated to systemic signs 
(i.e., fever) requiring antibiotic administration”.
• Success was defined as “complete wound closure, no dis-
charge, no pain in the area of surgery both spontaneously 
or during palpation, no signs of infection/inflammation”.
Statistical analysis
Descriptive statistics were reported as absolute frequencies 
and percentages for qualitative data. Median with range was 
used for categorical variables. Mean and standard deviation 
was used for continuous variables. Chi square test, Fisher 
Exact and t test were used to compare outcome measures 
in different subgroups of patients based on possible risk 
factors, namely BMI, previous recurrences and number of 
fistulas. A p lower than 0.05 was considered as statistically 
significant.
Results
During the study period, 43 patients aged less than 18 years 
were included. Mean age at surgery was 15 ± 1.4 years. 
Male-to-female ratio was 0.87:1. Two patients had co-mor-
bidities: brainstem tumor and congenital heart malformation. 
None reported clotting abnormalities or immunodeficiency. 
Mean weight at surgery was 67 ± 12.5 kg, mean height 
was 168 ± 10.6 cm. Mean BMI was 23 ± 3.5. Six out of 43 
patients previously underwent 11 ineffective sinus removal 
with a “lay open” healing technique to deal with pilonidal 
disease. One of these patients experienced 6 recurrences. 
Preoperative imaging was performed in 14 patients (32%) 
before referral for EPSiT. Imaging included eight ultrasound 
scan (USS) and six magnetic resonance imaging (MRI) that 
provided confirmation of the abscesses and fistula without 
adding any further information. Pilonidal sinus presented 
with chronic discharge in 38 (88%) and abscess with or with-
out fistulisation in 5 (12%). Up to 3 fistula were recorded 
preoperatively. Fistula were detected in the midline in 33 
patients (77%) and laterally in the remaining 10.
Anaesthesia was general with endotracheal intubation 
in 11 patients, spinal in 17, local in 12 and blended in 3. 
Mean length of EPSiT procedure was 34 ± 7.2  min. In 
case of a previous ineffective procedure length of EPSiT 
was 35 ± 3.7 min (p = 0.7414). Antibiotic prophylaxis was 
administered in 29 patients (cefazoline 40 mg/kg up to a 
maximum of 2 g). Fourteen patients did not receive any anti-
biotic prophylaxis. Mean VAS score was 2 ± 1.6 six hours 
postoperatively. Local anaesthesia provided the worst pain 
management with a mean VAS score of 3.2 ± 1.1, which 
proved to be significantly higher when compared to general 
and spinal anaesthesia that, respectively, scored 0.2 ± 0.4 
and 2.06 ± 0.6 (p < 0.0001 and p = 0.0004, respectively) 
(Table 1). Median length of hospital stay was 24 h (range 
12–72 h).
Median length of follow-up was 4  months (range 
3–16 months). Complete healing occurred in 38 patients 
(88%) after a median of 3 weeks (range 2–6 weeks). Over-
all, six patients (16%) experienced a total of nine compli-
cations. Five patients experienced recurrences (12%), two 
patients reported granuloma in the site of endoscopy that 
was treated with silver nitrate applications (5%), and two 
patients reported delayed healing (5%). One patient (2%) 
experienced surgical site infection. Four patients required 
reoperation (9%) and two of them demonstrated persistence 
of subcentrimetic subcutaneous cavitation at surgery but no 
true recurrence at all.
Comparing the incidence of complications based on dif-
ferent risk factors (antibiotic prophylaxis, number and type 
of fistulas, BMI) none proved to significantly interfere with 
the outcome. Of note, BMI in patients who experienced 
complications was higher (24.97 ± 6.33 versus 23.31 ± 2.84) 
but the difference proved not to be be statistically significant 
(p = 0.2955, see Table 1 for details).
Discussion
In the last decades various published papers and reports 
regarding treatment of pilonidal disease in children 
addressed many available options, including primary mid-
line repair [8, 9] open healing [1, 7], lateralized full-thick-
ness flaps [13, 14], fibrin sealant [5], phenol application [15] 
and even hair epilation alone [4].
Endoscopic pilonidal sinus treatment (EPSiT) has been 
described in 2013 by Meinero et al. [11] and quickly gained 
popularity in adult practice [12]. The first reported series in 
pediatrics is that by Esposito et al. (Authors CE and ME in 
this study) who reported a series of 15 patients who under-
went EPSiT procedure for noninfected pilonidal sinuses 
[16]. The authors demonstrated feasibility and safety of 
the technique and excluded complications or recurrences 
[16]. Our multicentre study included most of the patients 
belonging to the paper published by Esposito et al. (15 out 
of 17 patients) [16] and basically confirmed their results in 
a larger series and with higher consistency. Given the size 
of our series, we could provide more realistic outcome data 
and complication rates that proved to overlap those already 
reported in adults clinical practice [11, 12].
Although this aspect did not represent a focus of our 
study, we could observe that preoperative imaging for classic 
pilonidal disease is unnecessary. In fact, both USS and MRI 
proved to be of no use (both diagnosis and treatmentwise) 
in our series of patients.
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When coming to the most salient aspects of the study, 
we could demonstrate that EPSiT procedure is feasible both 
under general and regional or local anaesthesia in children 
as it is in adults. EPSiT is not painless but postoperative pain 
control proved to be satisfactory with the use of routine pain-
relief medications. In fact, postoperative pain remained well 
within acceptable ranges (mean VAS was 2 ± 1.4). Although 
local anaesthesia provided the worst pain control, mean 
postoperative VAS score was reasonable and confirmed the 
applicability of all concepts of fast track care with quick 
return to normal daily activities. In fact, EPSiT has been 
performed either as an outpatient or as a day case procedure 
with a hospital stay that was short as 12 h.
Complete wound healing proved to occur earlier in case 
of EPSiT when compared to other available procedures [11, 
12, 16]. Complete healing in EPSiT was reported after an 
average of 1 month postoperatively and this proved to be 
shorter compared to what reported for both open and closed 
Table 1  Details regarding 
our series of patients who 
underwent EPSiT
Both general and spinal anaesthesia yielded better pain control compared to local anaesthesia alone. BMI 
effect was not statistically significant but showed an interesting trend (p = 0.2801)
M:F male to female, BMI body mass index, SD standard deviation, MRI magnetic resonance imaging, USS 
ultrasound scan
Demographics N (%)
 Total patients 43 (100)
 Males 20 (53)
 Females 23 (47)
 M:F ratio 0.87:1
Patients’ features Mean ± SD
 Age at surgery (years) 15 ± 1.4
 Weight at surgery (Kg) 67 ± 12.5
 Height at surgery (cm) 168 ± 10.6
 BMI at surgery 23 ± 3.5
Preoperative history N (%)
 Preoperative MRI 6 (14)
 Preoperative USS 8 (19)
 Previous surgery 6 (14)
Clinical features Median (range) Complications p
 Number of fistulas 1 (1–3)
 More than 1 fistula 17 (39%) 2/17 1.0000
Fistula tract N (%)
 Midline fistulas 33 (77)
 Lateral fistulas 10 (23)
Clinical details Mean ± SD Issue p p
Antibiotics N (%) Complications
 Antibiotic prophylaxis 29 (67) 4/29 1.0000
Anaesthesiologic plan N (%) Pain (VAS)
 General anaesthesia 11 (26) 0.2 ± 0.4 0.0001 0.0001
 Spinal anaesthesia 17 (39) 2.06 ± 0.6 0.0004
 Local anaesthesia 15 (35) 3.2 ± 1.1
Length of surgery, hospital stay and F-Up
 Length of surgery (min) 34 ± 7.2
 Hospital stay (h) 24 (12–72)
 Length of follow-up (months) 4 (3–16)
Results N (%) BMI
 Complete healing 38 (88) 23.31 ± 2.85 0.2801
 Overall patients with complications 6 (14) 24.97 ± 6.33
 Recurrence 5 (12)
 Granuloma 2 (5)
 Delayed healing 2 (5)
 Reoperation 4 (9)
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repair thus confirming the effectiveness of the procedure [1, 
3, 6–10, 13]. Furthermore, EPSiT showed a relatively low 
incidence of complications, being recurrences, infections 
and reoperation rates basically halved (overall 14% versus 
over 30% for other techniques) [1, 4, 5, 7–9, 13, 15].
In particular, infections following EPSiT proved to be 
extremely rare. Of note, a meta-analysis by McCallum 
et al. in 2008, comparing open versus closed repair of pilo-
nidal sinuses, reported an infection rate of up to 22% [13]. 
Although the authors themselves underlined that most of 
papers reported relatively low infection rates, the results of 
EPSiT in our series showed infections to be nearly absent. 
Most of the patients in our series were treated with antibi-
otic prophylaxis (30 out of 43) and its use did not seem to 
interfere with the incidence of complications (p = 0.3023). 
Although, the only patient who developed infection did not 
receive antibiotic prophylaxis perioperatively, the relatively 
small series does not allow to draw definitive conclusions 
on this regard. On the ground of these considerations we 
cannot provide evidence-based recommendations but sug-
gest to administer a short term prophylaxis in a single-shot 
administration of Cefazoline 40 mg/kg (max dose 2 g).
Recurrence and reoperation rates have been reported to be 
around 25% in previous paediatric published series, regard-
less of the adopted procedure [1, 4, 5, 7–9, 13, 15].
EPSiT proved to be more effective as we observed a 
halved incidence of recurrence. As a consequence, reopera-
tions were required by only less than 10% of our patients.
Focusing on possible risk factors for complications, noth-
ing turned out to be statistically significant. Although com-
plications occurred in patients with the highest BMI, even 
this issue turned out not to be significantly correlated. None-
theless, we cannot exclude that larger series could disclose 
the potential role of BMI as a risk factor predictive for com-
plications in children, as previously reported [10] (Table 1).
EPSiT proved to be feasible and safe even for redo. In 
fact, the similar results of EPSiT (length of procedure and 
results) in redo compared to overall series confirmed its ver-
satility and its possible role even as a second-line treatment 
for patients whose first therapeutic choice was different.
Recently, some authors advocated the use of hair epila-
tion alone for the treatment of pilonidal disease [4]. None-
theless, results resemble those of other available options as 
subcutaneous retained hair or follicles are not removed, thus 
facilitating recurrences and infections. Anyway, based on 
these reports, we are can speculate that postoperative hair 
epilation could be proposed to our patients, to maximize the 
results of EPSiT and to reduce the likelihood of recurrences.
A limitation of our study is represented by the relatively 
short median follow-up that could limit the possibility to 
identify late recurrences, as those reported by Meinero 
et al. in a recent prospective multicentre trial [12]. Another 
limitation is represented by the absence of comparison of 
the results of our series with those of other commonly per-
formed techniques, either retrospective or prospective. In 
fact, we could only compare our results with available lit-
erature data and reports. Nonetheless, given the excellent 
results provided by EPSiT, at least in our series of patients, 
we can conclude that endoscopic pilonidal sinus treatment 
(EPSiT) in paediatric population represents a safe, effective 
and versatile option for the treatment of pilonidal diseases 
that could become the gold standard for its treatment in the 
next future.
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